Download PDF
Semin Respir Crit Care Med 2017; 38(03): 245-252
DOI: 10.1055/s-0037-1602581
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Should We Immediately Start Antibiotics in Every Patient with a Clinical Suspicion of HAP/VAP?

Taryn E. Hassinger
1   Department of Surgery, The University of Virginia Health System, Charlottesville, Virginia
,
Robert G. Sawyer
1   Department of Surgery, The University of Virginia Health System, Charlottesville, Virginia
2   Division of Acute Care and Trauma Surgery, The University of Virginia Health System, Charlottesville, Virginia
› Author Affiliations
Further Information

Publication History

Publication Date:
04 June 2017 (online)

    Permissions and Reprints

Abstract

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) remain two of the most commonly diagnosed nosocomial infections. Both are responsible for significant morbidity and mortality in hospitalized patients. The development of HAP and VAP is related to bacterial colonization of the oropharynx (and endotracheal tube in VAP) with subsequent microaspiration and development of clinical infection. Diagnosis is made based on the clinical presentation and can be confirmed by obtaining either noninvasive or invasive microbiology culture specimens. Decisions addressing initiation of antimicrobial therapy can be divided into clinical and bacteriological strategies. These strategies differ in the criteria used to determine the timing of empiric therapy, with the clinical strategy basing the decision on radiographic evidence of infection plus clinical signs and symptoms and the bacteriological strategy requiring growth of pathogens above a certain threshold from invasively obtained culture specimens. Despite the delineated pathways, these decisions remain multifactorial and should also include consideration of patient-related factors, such as immunocompetence, the risk of multidrug-resistant infection, and overall clinical condition. Patients with risk factors or signs of clinical decompensation should have empiric therapy initiated at a lower threshold. However, when possible, therapy should be directed at a confirmed infection following a positive culture result. Decisions regarding specific empiric regimens should be based on the local prevalence of infectious microorganisms along with their associated antimicrobial susceptibilities. Patients deemed at risk of infection with multidrug-resistant pathogens merit broader spectrum therapy, and immunosuppressed patients should have consideration of antifungal coverage.

Keywords

hospital-acquired pneumonia - ventilator-associated pneumonia - quantitative culture - empiric antimicrobial therapy - multidrug resistance
 

  • References

  • 1 American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171 (04) 388-416
    CrossrefPubMedGoogle Scholar
  • 2 Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. ; CDC; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53 (RR-3): 1-36
    PubMedGoogle Scholar
  • 3 Magill SS, Edwards JR, Fridkin SK. ; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Survey of health care-associated infections. N Engl J Med 2014; 370 (26) 2542-2543
    CrossrefPubMedGoogle Scholar
  • 4 Wang Y, Eldridge N, Metersky ML. , et al. National trends in patient safety for four common conditions, 2005-2011. N Engl J Med 2014; 370 (04) 341-351
    CrossrefPubMedGoogle Scholar
  • 5 Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33 (10) 2184-2193
    CrossrefPubMedGoogle Scholar
  • 6 Cook DJ, Walter SD, Cook RJ. , et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129 (06) 433-440
    CrossrefPubMedGoogle Scholar
  • 7 Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G. Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med 1987; 13 (05) 342-346
    CrossrefPubMedGoogle Scholar
  • 8 Melsen WG, Rovers MM, Groenwold RH. , et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013; 13 (08) 665-671
    CrossrefPubMedGoogle Scholar
  • 9 Muscedere JG, Day A, Heyland DK. Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. Clin Infect Dis 2010; 51 (Suppl. 01) S120-S125
    CrossrefPubMedGoogle Scholar
  • 10 Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol 2012; 33 (03) 250-256
    CrossrefPubMedGoogle Scholar
  • 11 Warren DK, Shukla SJ, Olsen MA. , et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31 (05) 1312-1317
    CrossrefPubMedGoogle Scholar
  • 12 Rello J, Ollendorf DA, Oster G. , et al; VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122 (06) 2115-2121
    CrossrefPubMedGoogle Scholar
  • 13 Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903
    CrossrefPubMedGoogle Scholar
  • 14 Blot S, Koulenti D, Dimopoulos G. , et al. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients. Crit Care Med 2014; 42: 601-609
    CrossrefPubMedGoogle Scholar
  • 15 Sopena N, Sabrià M. ; Neunos 2000 Study Group. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 2005; 127 (01) 213-219
    CrossrefPubMedGoogle Scholar
  • 16 Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010; 51 (Suppl. 01) S81-S87
    CrossrefPubMedGoogle Scholar
  • 17 Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005; 50 (06) 725-739 , discussion 739–741
    PubMedGoogle Scholar
  • 18 Garrouste-Orgeas M, Chevret S, Arlet G. , et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997; 156 (05) 1647-1655
    CrossrefPubMedGoogle Scholar
  • 19 Kallet RH. The vexing problem of ventilator-associated pneumonia: observations on pathophysiology, public policy, and clinical science. Respir Care 2015; 60 (10) 1495-1508
    CrossrefPubMedGoogle Scholar
  • 20 Kollef MH. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004; 32 (06) 1396-1405
    CrossrefPubMedGoogle Scholar
  • 21 Richards MJ, Edwards JR, Culver DH, Gaynes RP. ; National Nosocomial Infections Surveillance System. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999; 27 (05) 887-892
    CrossrefPubMedGoogle Scholar
  • 22 Chastre J, Trouillet JL, Vuagnat A. , et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157 (4 Pt 1): 1165-1172
    CrossrefPubMedGoogle Scholar
  • 23 Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007; 28 (07) 825-831
    CrossrefPubMedGoogle Scholar
  • 24 Rello J, Torres A, Ricart M. , et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150 (6 Pt 1): 1545-1549
    CrossrefPubMedGoogle Scholar
  • 25 Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94 (03) 281-288
    CrossrefPubMedGoogle Scholar
  • 26 Kalil AC, Metersky ML, Klompas M. , et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63 (05) 575-582
    CrossrefPubMedGoogle Scholar
  • 27 Trouillet JL, Chastre J, Vuagnat A. , et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157 (02) 531-539
    CrossrefPubMedGoogle Scholar
  • 28 Martin-Loeches I, Deja M, Koulenti D. , et al; EU-VAP Study Investigators. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 2013; 39 (04) 672-681
    CrossrefPubMedGoogle Scholar
  • 29 Restrepo MI, Peterson J, Fernandez JF, Qin Z, Fisher AC, Nicholson SC. Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies. Respir Care 2013; 58 (07) 1220-1225
    CrossrefPubMedGoogle Scholar
  • 30 Bouza E, Giannella M, Bunsow E. , et al; Gregorio Marañón Task Force for Pneumonia (GANG). Ventilator-associated pneumonia due to meticillin-resistant Staphylococcus aureus: risk factors and outcome in a large general hospital. J Hosp Infect 2012; 80 (02) 150-155
    CrossrefPubMedGoogle Scholar
  • 31 Wooten DA, Winston LG. Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia. Respir Med 2013; 107 (08) 1266-1270
    CrossrefPubMedGoogle Scholar
  • 32 Lollar DI, Rodil M, Herbert B, Burlew CC, Pieracci FM. Empiric methicillin resistant Staphylococcus aureus coverage in the early ventilator associated pneumonia window: if and when. Surg Infect (Larchmt) 2016; 17 (02) 187-190
    CrossrefPubMedGoogle Scholar
  • 33 Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39 (06) 776-782
    CrossrefPubMedGoogle Scholar
  • 34 Robicsek A, Suseno M, Beaumont JL, Thomson Jr RB, Peterson LR. Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol 2008; 46 (02) 588-592
    CrossrefPubMedGoogle Scholar
  • 35 Dangerfield B, Chung A, Webb B, Seville MT. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother 2014; 58 (02) 859-864
    CrossrefPubMedGoogle Scholar
  • 36 Garau J, Gomez L. Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 2003; 16 (02) 135-143
    CrossrefPubMedGoogle Scholar
  • 37 Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. Am J Respir Crit Care Med 1997; 156 (4 Pt 1): 1092-1098
    CrossrefPubMedGoogle Scholar
  • 38 Meduri GU. Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clin Chest Med 1995; 16 (01) 61-93
    PubMedGoogle Scholar
  • 39 Schleupner CJ, Cobb DK. A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital. Infect Control Hosp Epidemiol 1992; 13 (09) 515-525
    CrossrefPubMedGoogle Scholar
  • 40 Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122 (01) 262-268
    CrossrefPubMedGoogle Scholar
  • 41 Parker CM, Kutsogiannis J, Muscedere J. , et al; Canadian Critical Care Trials Group. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 2008; 23 (01) 18-26
    CrossrefPubMedGoogle Scholar
  • 42 Fàbregas N, Ewig S, Torres A. , et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54 (10) 867-873
    CrossrefPubMedGoogle Scholar
  • 43 Karhu JM, Ala-Kokko TI, Ahvenjärvi LK, Rauvala E, Ohtonen P, Syrjälä HP. Early chest computed tomography in adult acute severe community-acquired pneumonia patients treated in the intensive care unit. Acta Anaesthesiol Scand 2016; 60 (08) 1102-1110
    CrossrefPubMedGoogle Scholar
  • 44 Kirtland SH, Corley DE, Winterbauer RH. , et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997; 112 (02) 445-457
    CrossrefPubMedGoogle Scholar
  • 45 Blot F, Raynard B, Chachaty E, Tancrède C, Antoun S, Nitenberg G. Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 2000; 162 (05) 1731-1737
    CrossrefPubMedGoogle Scholar
  • 46 Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis 2010; 51 (Suppl. 01) S131-S135
    CrossrefPubMedGoogle Scholar
  • 47 Schurink CA, Van Nieuwenhoven CA, Jacobs JA. , et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med 2004; 30 (02) 217-224
    CrossrefPubMedGoogle Scholar
  • 48 Fagon JY, Chastre J, Wolff M. , et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000; 132 (08) 621-630
    PubMedGoogle Scholar
  • 49 Baker AM, Bowton DL, Haponik EF. Decision making in nosocomial pneumonia. An analytic approach to the interpretation of quantitative bronchoscopic cultures. Chest 1995; 107 (01) 85-95
    CrossrefPubMedGoogle Scholar
  • 50 Niederman MS, Torres A, Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am J Respir Crit Care Med 1994; 150 (02) 565-569
    CrossrefPubMedGoogle Scholar
  • 51 Wermert D, Marquette CH, Copin MC. , et al. Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia. Am J Respir Crit Care Med 1998; 158 (01) 139-147
    CrossrefPubMedGoogle Scholar
  • 52 Hranjec T, Rosenberger LH, Swenson B. , et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 2012; 12 (10) 774-780
    CrossrefPubMedGoogle Scholar
  • 53 Ramsamy Y, Muckart DJ, Bruce JL, Hardcastle TC, Han KS, Mlisana KP. Empirical antimicrobial therapy for probable v. directed therapy for possible ventilator-associated pneumonia in critically injured patients. S Afr Med J 2016; 106 (02) 196-200
    CrossrefPubMedGoogle Scholar
  • 54 Fartoukh M, Maitre B, Honoré S, Cerf C, Zahar JR, Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003; 168 (02) 173-179
    CrossrefPubMedGoogle Scholar
  • 55 Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357 (25) 2601-2614
    CrossrefPubMedGoogle Scholar
  • 56 Leiten EO, Martinsen EM, Bakke PS, Eagan TM, Grønseth R. Complications and discomfort of bronchoscopy: a systematic review. Eur Clin Respir J 2016; 3: 33324
    PubMedGoogle Scholar
  • 57 Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160 (02) 608-613
    CrossrefPubMedGoogle Scholar
  • 58 Ewig S, Torres A, El-Ebiary M. , et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 1999; 159 (01) 188-198
    CrossrefPubMedGoogle Scholar
  • 59 Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29 (06) 1109-1115
    CrossrefPubMedGoogle Scholar
  • 60 Sievert DM, Ricks P, Edwards JR. , et al; National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013; 34 (01) 1-14
    CrossrefPubMedGoogle Scholar
  • 61 Graman PS, Hall CB. Epidemiology and control of nosocomial viral infections. Infect Dis Clin North Am 1989; 3 (04) 815-841
    PubMedGoogle Scholar
  • 62 Graman PS, Hall CB. Nosocomial viral respiratory infections. Semin Respir Infect 1989; 4 (04) 253-260
    PubMedGoogle Scholar
  • 63 Nguyen C, Kaku S, Tutera D, Kuschner WG, Barr J. Viral respiratory infections of adults in the intensive care unit. J Intensive Care Med 2016; 31 (07) 427-441
    CrossrefPubMedGoogle Scholar
  • 64 Martínez-Hernández L, Vilar-Compte D, Cornejo-Juárez P, Volkow-Fernández P. Nosocomial pneumonia in patients with haematological malignancies [in Spanish]. Gac Med Mex 2016; 152 (04) 465-472
    PubMedGoogle Scholar
  • 65 Evans SE, Ost DE. Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med 2015; 21 (03) 260-271
    PubMedGoogle Scholar
  • 66 el-Ebiary M, Torres A, Fàbregas N. , et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 1997; 156 (2 Pt 1): 583-590
    CrossrefPubMedGoogle Scholar